ΑΡΘΡΟΓΡΑΦΙΑ - ΕΠΙΣΗΜΑ ΔΕΟΜΕΝΑ για IBD και COVID-19

- IDSA release
- SECURE-IBD COVID-19 weekly update #4
- COVID-19 Current Data - Date last updated: 3/27/2020
- Body positioning may affect lung recruitability in COVID-19-related ARDS
- 'Every clinician is also a patient': Study shows psychological impact of COVID-19 pandemic on health care workers
- What Should Gastroenterologists and Patients Know About COVID-19?
- Discovering drugs to treat coronavirus disease 2019 (COVID-19)
- National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
- Protection of 318 inflammatory bowel disease patients from the outbreak and rapid spread of COVID-19 infection in Wuhan, China (The Lancet)
- Implications of COVID-19 for patients with pre-existing digestive diseases (The LANCET)
- IBD LIVE: Update on COVID-19 and what it means for our patients (Cleveland Clinic)
- ΚΟΙΝΟ ΜΗΝΥΜΑ ΤΩΝ ΑΜΕΡΙΚΑΝΙΚΩΝ ΕΠΙΣΤΗΜΟΝΙΚΩΝ ΕΤΑΙΡΕΙΩΝ ΓΑΣΤΡΕΝΤΕΡΟΛΟΓΙΑΣ, ΕΝΔΟΣΚΟΠΗΣΗΣ ΠΕΠΤΙΚΟΥ, ΗΠΑΤΟΛΟΓΙΑΣ ΚΑΙ ΤΟΥ ΑΜΕΡΙΚΑΝΙΚΟΥ ΚΟΛΛΕΓΙΟΥ ΓΑΣΤΡΕΝΤΕΡΟΛΟΓΙΑΣ
- Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection
- Coronavirus: Armageddon or Rubbish? article written on Monday March 2, 2020.
- INTERIM CLINICAL GUIDANCE FOR PATIENTS SUSPECTED OF/CONFIRMED WITH COVID-19 IN BELGIUM
- Commentary Of chloroquine and COVID-19
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the T reatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- IOIBD Update on COVID19 for Patients with Crohn’s Disease and Ulcerative Colitis
- Guidelines for the treatment of people with COVI-19 disease Edition 2.0, 13 March 2020 Italian Society of Infectious and Tropical Diseases
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19